ECMO use in Germany: An analysis of 29,929 ECMO runs.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 10 06 2021
accepted: 06 11 2021
entrez: 7 12 2021
pubmed: 8 12 2021
medline: 7 1 2022
Statut: epublish

Résumé

Extracorporeal Membrane Oxygenation (ECMO) use is increasing despite limited evidence. The aim of this study was to demonstrate heterogeneity of ECMO use and its association with hospital size and annual frequency in Germany. This is a database analysis of all ECMO cases in Germany from 2010 to 2016 using the German Diagnosis Related Groups (DRG) coding system for ECMO. During the study period, 510 hospitals performed 29,929 ECMO runs (12,572 vvECMO, 11,504 vaECMO, 1993 pECLA) with an increase over time. Mortality ranged between 58% and 66% for vaECMO cases and 66% and 53% for vvECMO cases. 304 (61%) hospitals performed only one ECMO per year. 78%% of all ECMO runs were performed in centres with more than 20 cases per year and more than half of all ECMO runs were performed in hospitals with >1.000 beds. Mortality for vv and vaECMO was highest in very small hospitals (< 200 beds; 70%; 74%) and very large hospitals (>1000 beds; 60%; 62%). Use of ECMO is still increasing and a substantial proportion of hospitals performs very few ECMO runs. Small hospitals had a significantly higher mortality, but dependence on hospital size and ECMO mortality was irregular.

Sections du résumé

BACKGROUND
Extracorporeal Membrane Oxygenation (ECMO) use is increasing despite limited evidence. The aim of this study was to demonstrate heterogeneity of ECMO use and its association with hospital size and annual frequency in Germany.
METHODS
This is a database analysis of all ECMO cases in Germany from 2010 to 2016 using the German Diagnosis Related Groups (DRG) coding system for ECMO.
RESULTS
During the study period, 510 hospitals performed 29,929 ECMO runs (12,572 vvECMO, 11,504 vaECMO, 1993 pECLA) with an increase over time. Mortality ranged between 58% and 66% for vaECMO cases and 66% and 53% for vvECMO cases. 304 (61%) hospitals performed only one ECMO per year. 78%% of all ECMO runs were performed in centres with more than 20 cases per year and more than half of all ECMO runs were performed in hospitals with >1.000 beds. Mortality for vv and vaECMO was highest in very small hospitals (< 200 beds; 70%; 74%) and very large hospitals (>1000 beds; 60%; 62%).
CONCLUSIONS
Use of ECMO is still increasing and a substantial proportion of hospitals performs very few ECMO runs. Small hospitals had a significantly higher mortality, but dependence on hospital size and ECMO mortality was irregular.

Identifiants

pubmed: 34874960
doi: 10.1371/journal.pone.0260324
pii: PONE-D-21-19126
pmc: PMC8651096
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0260324

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

JAMA. 2009 Nov 4;302(17):1888-95
pubmed: 19822628
Respiration. 2019;98(4):357-372
pubmed: 31505511
Ann Thorac Surg. 2017 Jul;104(1):62-69
pubmed: 28131429
J Thorac Dis. 2015 Jul;7(7):E166-76
pubmed: 26380745
Am J Surg. 2000 Aug;180(2):144-54
pubmed: 11044532
JAMA. 2011 Oct 19;306(15):1659-68
pubmed: 21976615
Intensive Care Med. 2020 Dec;46(12):2464-2476
pubmed: 33140180
BMJ Open Respir Res. 2019 May 24;6(1):e000420
pubmed: 31258917
BMJ Open. 2017 Sep 6;7(9):e016184
pubmed: 28882913
Intensive Care Med. 2016 May;42(5):889-896
pubmed: 26942446
Ann Thorac Surg. 2014 Feb;97(2):610-6
pubmed: 24210621
Am J Respir Crit Care Med. 1994 Feb;149(2 Pt 1):295-305
pubmed: 8306022
JAMA. 1979 Nov 16;242(20):2193-6
pubmed: 490805
Chest. 1997 Sep;112(3):759-64
pubmed: 9315812
N Engl J Med. 2018 May 24;378(21):1965-1975
pubmed: 29791822
Am J Respir Crit Care Med. 1995 Apr;151(4):1121-5
pubmed: 7697241
Intensive Care Med. 2001 Oct;27(10):1643-8
pubmed: 11685306
Ann Surg. 2004 Oct;240(4):595-605; discussion 605-7
pubmed: 15383787
BMC Health Serv Res. 2006 Dec 23;6:163
pubmed: 17187683
Am J Respir Crit Care Med. 2015 Apr 15;191(8):894-901
pubmed: 25695688
N Engl J Med. 1972 Mar 23;286(12):629-34
pubmed: 5060491
Intensive Care Med. 2009 Dec;35(12):2105-14
pubmed: 19768656

Auteurs

Sven Bercker (S)

Department of Anesthesiology and Intensive Care Medicine, University of Leipzig Medical Faculty, Leipzig, Germany.

David Petroff (D)

Clinical Trial Centre, University of Leipzig, Leipzig, Germany.

Nina Polze (N)

Department of Anesthesiology and Intensive Care Medicine, University of Leipzig Medical Faculty, Leipzig, Germany.

Christian Karagianidis (C)

Department of Pneumology and Critical Care Medicine, Cologne-Merheim Hospital, ARDS and ECMO Centre, Kliniken der Stadt Köln gGmbH, Witten/Herdecke University Hospital, Cologne, Germany.

Thomas Bein (T)

Department of Anesthesiology and Critical Care Medicine, Faculty of Medicine, University of Regensburg, Regensburg, Germany.

Sven Laudi (S)

Department of Anesthesiology and Intensive Care Medicine, University of Leipzig Medical Faculty, Leipzig, Germany.

Sebastian N Stehr (SN)

Department of Anesthesiology and Intensive Care Medicine, University of Leipzig Medical Faculty, Leipzig, Germany.

Maria Theresa Voelker (MT)

Department of Anesthesiology and Intensive Care Medicine, University of Leipzig Medical Faculty, Leipzig, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH